LabCompass

Urs von Holzen

Medicine · Indiana University

Mid career · publishing since 2005

Publications

118

Citations

1,092

Est. group size

~2

Recurring co-author estimate

Active years

22

Publishing since 2005

Research summary
AI-generated

Urs von Holzen conducts laboratory-based cancer research focused on gastrointestinal malignancies, particularly esophageal adenocarcinoma (cancer of the food pipe), pancreatic cancer, and related digestive-system tumors. The work centers on testing molecular-targeted drugs and drug combinations—such as inhibitors of specific proteins involved in tumor growth and metabolism—to improve treatment responses in experimental models. Studies typically combine cell and tissue analysis with preclinical evaluation of candidate therapies.

Esophageal adenocarcinoma biology and treatmentPancreatic cancer targeted therapy (e.g., KRAS inhibitors)Molecular drug targets and enzyme inhibitorsCombination and chemotherapy response strategiesGastrointestinal and hepatobiliary oncology

Publication output has been fairly steady across the decade with year-to-year fluctuation, peaking around 2023 and averaging roughly 8 papers per year over the last five years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026

In context
Among 4,618 mid career Medicine PIs within our index
Citations: 1,092cohort median 616
h-index: 17cohort median 11
Publications / year (recent): 7.8cohort median 3.4

Typically publishes in teams of ~7 · 8% small-team papers (≤3 authors) · across 44 venues

Publication cadence
Publications per year over the last 10 years — averaging 7.8/year recently
2017: 8 publications172018: 7 publications182019: 12 publications192020: 7 publications202021: 12 publications212022: 9 publications222023: 16 publications16232024: 4 publications242025: 7 publications252026: 3 publications26
Collaborators per year
Distinct co-authors at Indiana University each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
2017: 0 collaborators at the same institution2018: 1 collaborator at the same institution2019: 5 collaborators at the same institution2020: 0 collaborators at the same institution2021: 0 collaborators at the same institution2022: 3 collaborators at the same institution2023: 2 collaborators at the same institution2024: 3 collaborators at the same institution2025: 4 collaborators at the same institution1719212325
Recent publications
Publishes in
  • Cancer Research×24
  • PMC×3
  • Experimental and Molecular Therapeutics×3
  • BMC Cancer×2
  • Scientific Reports×2
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Sep 1, 2026.

Claim or correct this profile